Sarah Fry

Sarah Fry serves as the primary procurement lead for the National CMOP Office within the Department of Veterans Affairs, overseeing the acquisition of mission-critical pharmaceuticals, diagnostic substances, and medical consumables essential to veteran healthcare. Her role is central to advancing the agency’s strategic objective of sustaining sovereign domestic manufacturing capabilities, ensuring supply chain resilience against global disruptions. She manages a diverse portfolio of contracts spanning manufacturing, logistics, and quality assurance services, with a strong emphasis on compliance with federal acquisition regulations and national security requirements for pharmaceutical sovereignty. Fry maintains consistent contracting relationships with a core group of specialized vendors, including ALL IN SOLUTIONS LLC, ANSIBLE GOVERNMENT SOLUTIONS LLC, and INNOVATION ASSOCIATES, INC., each recognized for their expertise in pharmaceutical production and regulated medical supply chain operations. Her working model prioritizes long-term, performance-based partnerships with contractors who demonstrate robust GMP compliance, FDA alignment, and secure domestic production infrastructure, fostering reliability and accountability across the supply base. Her procurement strategy is deeply rooted in socioeconomic mandates, with over 60% of awards designated for Total Small Business Set-Asides under FAR 19.5, reflecting a strong institutional commitment to small business participation. She also regularly utilizes Service-Disabled Veteran-Owned Small Business (SDVOSB) set-asides, aligning with VA’s mission to support veteran entrepreneurs. Local Area Set-Asides under FAR 26.2 further reinforce community-based economic development goals within her acquisition framework. Fry’s technical focus centers on NAICS 325412 (Pharmaceutical Preparation Manufacturing), which accounts for more than 60% of her portfolio, alongside significant activity in 325413 (In-Vitro Diagnostic Substance Manufacturing). Her expertise spans sterile compounding, radiopharmaceuticals, and controlled-substance production, requiring deep familiarity with cGMP, USP <797>, and DEA regulatory frameworks. She consistently procures high-assurance medical products where purity, traceability, and domestic sourcing are non-negotiable for veteran health outcomes.